Rafferty Asset Management, LLC - PIERIS PHARMACEUTICALS INC ownership

PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 70 filers reported holding PIERIS PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.11 and the average weighting 0.2%.

Quarter-by-quarter ownership
Rafferty Asset Management, LLC ownership history of PIERIS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2022$55,000
-19.1%
29,622
+32.3%
0.00%
Q1 2022$68,000
-12.8%
22,382
+8.9%
0.00%
Q4 2021$78,000
-52.4%
20,547
-35.4%
0.00%
-100.0%
Q3 2021$164,00031,7960.00%
Other shareholders
PIERIS PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 3,196,527$16,526,0003.00%
BVF INC/IL 5,328,239$27,547,0001.08%
Soleus Capital Management, L.P. 740,000$3,826,0000.60%
Cutter & CO Brokerage, Inc. 326,100$1,686,0000.40%
EAM Investors, LLC 288,459$1,491,0000.25%
PLATINUM INVESTMENT MANAGEMENT LTD 1,028,322$5,316,0000.15%
Rhenman & Partners Asset Management AB 300,000$1,551,0000.11%
Navis Wealth Advisors, LLC 16,000$83,0000.06%
Sigma Planning Corp 364,484$1,884,0000.06%
XTX Topco Ltd 32,650$169,0000.06%
View complete list of PIERIS PHARMACEUTICALS INC shareholders